KORU Medical Systems (NASDAQ:KRMD) Given New $4.00 Price Target at Canaccord Genuity Group

KORU Medical Systems (NASDAQ:KRMD) had its target price boosted by Canaccord Genuity Group from $3.00 to $4.00 in a report published on Thursday,Benzinga reports. They currently have a buy rating on the stock.

KRMD has been the topic of several other research reports. Piper Sandler raised their price objective on shares of KORU Medical Systems from $3.00 to $3.50 and gave the company an “overweight” rating in a research report on Thursday. B. Riley began coverage on KORU Medical Systems in a research report on Thursday, July 25th. They set a “buy” rating and a $4.00 price objective for the company.

KORU Medical Systems Trading Up 2.9 %

KRMD stock opened at $3.17 on Thursday. KORU Medical Systems has a 12-month low of $1.98 and a 12-month high of $3.40. The company has a current ratio of 2.99, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average of $2.67 and a two-hundred day moving average of $2.48.

Institutional Trading of KORU Medical Systems

A number of institutional investors and hedge funds have recently modified their holdings of KRMD. Archon Capital Management LLC increased its holdings in KORU Medical Systems by 6.2% in the 1st quarter. Archon Capital Management LLC now owns 3,951,393 shares of the company’s stock valued at $9,325,000 after buying an additional 230,517 shares during the period. Meros Investment Management LP increased its stake in KORU Medical Systems by 20.7% in the second quarter. Meros Investment Management LP now owns 804,380 shares of the company’s stock valued at $2,132,000 after acquiring an additional 137,918 shares during the period. First Light Asset Management LLC increased its stake in KORU Medical Systems by 1.1% in the first quarter. First Light Asset Management LLC now owns 5,220,990 shares of the company’s stock valued at $12,322,000 after acquiring an additional 57,253 shares during the period. Vanguard Group Inc. raised its position in KORU Medical Systems by 2.7% in the first quarter. Vanguard Group Inc. now owns 1,961,764 shares of the company’s stock worth $4,630,000 after purchasing an additional 51,890 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in KORU Medical Systems during the second quarter worth about $107,000. 58.60% of the stock is currently owned by institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.